Treatment retention of risperidone long-acting injection in patients with early-onset schizophrenia in Japan

Asian J Psychiatr. 2017 Jun:27:137-138. doi: 10.1016/j.ajp.2017.02.024. Epub 2017 Mar 6.

Authors

Hidenobu Suzuki¹, Hiroyuki Hibino², Yuichi Inoue³, Atsuhiko Takaya²

Affiliations

¹ Department of Psychiatry, Suzuki Clinic [H.S.], 3-34-16 Hamadayama, Suginami, Tokyo 168-0065, Japan. Electronic address: suzuhiromarket@yahoo.co.jp.
² Department of Psychiatry, Fukui Kinen Hospital [H.H.], [A.T], Kanagawa 238-0115, Japan.
³ Department of Psychiatry, Shakomae Kokorono Clinic [Y.I.], Tokyo 116-0011, Japan.

PMID: 28558887
DOI: 10.1016/j.ajp.2017.02.024

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Age of Onset
Antipsychotic Agents / therapeutic use*
Child
Cohort Studies
Delayed-Action Preparations
Female
Humans
Japan
Male
Patient Compliance / psychology
Patient Compliance / statistics & numerical data*
Retrospective Studies
Risperidone / therapeutic use*
Schizophrenia / drug therapy*
Treatment Outcome
Young Adult

Substances

Antipsychotic Agents
Delayed-Action Preparations
Risperidone